Methodology for Conducting Post-Marketing Surveillance of Software as a Medical Device Based on Artificial Intelligence Technologies.
PMID: 37181834 ·
V V Zinchenko, K M Arzamasov, S F Chetverikov, A V Maltsev, V P Novik, E S Akhmad, D E Sharova, A E Andreychenko, A V Vladzymyrskyy, S P Morozov
Abstract
The aim of the study was to develop a methodology for conducting post-registration clinical monitoring of software as a medical device based on artificial intelligence technologies (SaMD-AI). The methodology of post-registration clinical monitoring is based on the requirements of regulatory legal acts issued by the Board of the Eurasian Economic Commission. To comply with these requirements, the monitoring involves submission of the review of adverse events reports, the review of developers' rou
Official Source
View on PubMed →Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.